EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioinformatics Analysis and Experimental Validation of ASF1B in Breast Tumors

Wenhao Xing iD, Meng Deng, Wendong Wang iD, Yueqi Liu, Xuefang Mi, Huixia Li, Xin Ge

Cancer Medicine · 2025-09 · 14 (18)

DOI: 10.1002/cam4.71073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 13.09.2025. Verfasst von Wenhao Xing und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Cell Cycle Proteins, Computational Biology, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cultivation of Young and Middle-aged Talents in Health Science and Technology Innovation, Program for Tackling Key Problems in Medical Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the association between ASF1B expression and pathological characteristics of breast cancer, and to further explore its role in tumor progression and the immune microenvironment, thereby evaluating its potential as a therapeutic target.

Methods

ASF1B expression in breast cancer was analyzed using the GEPIA2 and BEST databases. Its association with patient prognosis was assessed using Kaplan–Meier survival analysis. Protein co‐expression networks were constructed using GeneMANIA. The correlation between ASF1B expression and immune cell infiltration was evaluated through the TIMER platform. Experimental validation was performed using qPCR and immunohistochemistry (IHC) on 67 breast cancer tissue samples.

Results

ASF1B expression was significantly elevated in breast cancer tissues compared to normal tissues ( p < 0.05). High ASF1B expression was associated with reduced overall and recurrence‐free survival ( p < 0.05). Protein interaction analysis revealed that ASF1B was strongly linked to proteins involved in DNA replication, cell cycle progression, and chromatin remodeling. Immune analysis indicated positive correlations with B cells, neutrophils, and dendritic cells and a negative correlation with macrophage infiltration ( p < 0.05). Clinical data further showed that high ASF1B expression was significantly associated with HER2‐positive breast cancer ( p = 0.026).

Conclusion

ASF1B is highly expressed in breast cancer and correlates with poor prognosis and immune cell infiltration. It may serve as a potential prognostic biomarker and therapeutic target in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCell Cycle ProteinsComputational BiologyBiomarkers, TumorHumansFemalePrognosisGene Expression Regulation, NeoplasticTumor MicroenvironmentKaplan-Meier EstimateProtein Interaction MapsMiddle AgedImmunohistochemistry

Stichwörter der Autor:innen

anti‐silencing function protein 1Bbreast cancerclinical prognosisimmune infiltration

Substanzen

Cell Cycle ProteinsBiomarkers, TumorASF1B protein, human

Autor:innen und Institutionen

  • Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Wenhao Xing, Wendong Wang

Förderung

  • Cultivation of Young and Middle-aged Talents in Health Science and Technology Innovation
  • Program for Tackling Key Problems in Medical Science and Technology

Zitieren

APA

Xing, W., Deng, M., Wang, W., Liu, Y., Mi, X., Li, H., & Ge, X. (2025). Bioinformatics Analysis and Experimental Validation of ASF1B in Breast Tumors. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71073

Vancouver

Xing W, Deng M, Wang W, Liu Y, Mi X, Li H, et al. Bioinformatics Analysis and Experimental Validation of ASF1B in Breast Tumors. Cancer Medicine. 2025;14(18). doi:10.1002/cam4.71073

BibTeX
@article{Xing2025,
  author = {Xing, Wenhao and Deng, Meng and Wang, Wendong and Liu, Yueqi and Mi, Xuefang and Li, Huixia and Ge, Xin},
  title = {Bioinformatics Analysis and Experimental Validation of ASF1B in Breast Tumors},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {18},
  doi = {10.1002/cam4.71073}
}
Kostenlos starten →